
Health Rounds: Roche/BioNTech experimental vaccine shows early promise in pancreatic cancer
March 5 (Reuters) - Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche (ROG.S), opens new tab and BioNTech (22UAy.DE), opens new tab following surgery in a small, early trial were still alive, most without disease recurrence, more than three years later, researchers reported.
Typically, the rare long-term survivors of this disease have immune systems that learn to recognize and attack mutant proteins, or neoantigens, in their cancer cells, the study authors noted in a published with their report.
The messenger RNA-based therapeutic cancer vaccine, autogene cevumeran, achieved the same effect in eight of the 16 trial participants, the researchers had earlier reported.
The researchers, whose findings were published in Nature, opens new tab, do not know why only some patients responded to the vaccine.
The vaccine was personalized to deliver instructions that would teach the immune system to recognize each patient's specific tumor cells. Study participants first received surgery, followed by the vaccine and Roche's immunotherapy Tecentriq (atezolizumab), and finally chemotherapy.
At a median follow-up of 3.2 years, six of the eight responders remain cancer-free. The two who relapsed had weaker vaccine-induced immune responses compared with other responders, the researchers reported.
Seven of the eight vaccine non-responders had cancer recurrences at a median of 13.4 months after surgery.
Early-stage trials are designed to test safety, not efficacy, so the researchers cannot say the vaccine caused the delay in cancer recurrence. A larger, mid-stage trial is underway that should be able to shed more insight into the vaccine's efficacy.
'For patients with pancreatic cancer, our latest results continue to support the approach of using personalized mRNA vaccines to target neoantigens in each patient's tumor,' study leader Dr. Vinod Balachandran of Memorial Sloan-Kettering Cancer Center in New York said in a statement.
EPSTEIN-BARR VIRUS BOOSTS CROHN'S DISEASE RISK
Epstein-Barr virus (EBV), which causes mononucleosis, can also increase a person's risk of developing Crohn's disease, a debilitating autoimmune condition of the gastrointestinal tract, researchers have discovered.
EBV is already known to contribute to higher risks for other autoimmune diseases, including multiple sclerosis, lupus and rheumatoid arthritis, but the association with Crohn's had not been recognized.
The researchers analyzed blood samples obtained periodically from a large cohort of young military recruits, looking for antibodies against a wide range of viruses.
Military personnel whose blood contained anti-EBV antibodies, showing they had once been infected, were three times more likely to eventually develop Crohn's disease compared to recruits without these antibodies, the researchers reported in Gastroenterology, opens new tab.
Participants' EBV infections likely preceded their Crohn's diagnosis by five-to-seven years, the researchers said.
Later, in a large group of children whose parents or siblings had Crohn's, the researchers could not find evidence that EBV infections increased the children's risk of developing the disease. They speculated that having first-degree relatives with Crohn's could already have put them at increased risk, muddying the association with EBV.
The researchers want to learn what the Epstein-Barr virus does at a molecular level to make people more susceptible to Crohn's disease.
'Mechanistically, we need to understand exactly how EBV alters the immune system leading to Crohn's disease,' study leader Dr. Scott Snapper of Boston Children's Hospital said in a statement. 'If you could figure out the mechanisms, you could come up with new therapies.'
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Reporting by Nancy Lapid; editing by Bill Berkrot
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Record
3 hours ago
- Daily Record
'I donated my mum's body to Alzheimer's research instead she was blown to pieces'
Her son said 'she was strapped in a chair, and a detonation took place underneath her' One Arizona man thought he was donating his mother's body to science after her harrowing descent in Alzheimer's - only to discover he had been sent her cremated arm before the rest of her body was strapped to a chair and blown up. Jim Stauffer cared for his mother Doris throughout her illness before she died at 74 in 2013. He decided to donate her brain to science hoping to contribute to a cure for Alzheimer's disease. The family contacted Biological Resource Center, a local company that brokered the donation of human bodies for research. Within the hour, BRC dispatched a driver to collect Doris. Jim signed a form authorizing medical research on his mother's body. Ten days later, Jim received his mother's cremated remains - but it turns out her ashes were made up of a singular arm sawn off from her body. The rest of her corpse had met a violent fate. Doris' brain never was used for Alzheimer's research. Instead, her body became part of an Army experiment to measure damage caused by roadside bombs, reports the Irish Star. Internal BRC and military records show that at least 20 other bodies were also used in the blast experiments without permission of the donors or their relatives, a violation of U.S. Army policy. Jim had also ticked a box specifically banning any kind of experiments on Doris. BRC sold donated bodies like Stauffer's for $5,893 each. Jim said: "She was strapped in a chair, and a detonation took place underneath her to get an idea of what the human body goes through when a vehicle is hit by an IED. There was wording on this paperwork about performing tests that may involve explosions, and we said, 'No'." Army officials involved in the project said they never received the consent forms that donors or their families had signed. Rather, the officials said they relied on assurances from BRC that families had agreed to let the bodies be used in such experiments. BRC, which sold more than 20,000 parts from some 5,000 human bodies over a decade, is no longer in business. Its former owner, Stephen Gore, pleaded guilty to fraud in 2022. In a statement to Reuters, Gore said that he always tried to honor the wishes of donors and sent consent forms when researchers requested them. Jim said of Gore "He didn't care about the families, he didn't care about the people." Jim learned of the fate of his mother's body from a Reuters reporter and "curled his lip in anger and clutched his wife Lisa's arm. "We did right," Lisa reassured him. "They just did not honor our wishes." No federal law regulates body brokers like BRC, and no U.S. government agency monitors what happens to cadavers pledged for use in medical education and research. "It is not illegal to sell a whole body or the parts of a body for research or education," said University of Iowa law professor Sheldon F. Kurtz, who helped modify the Uniform Anatomical Gift Act, which has been adopted by 46 states. Although the act was updated in 2006, Kurtz said, "the issue of whole bodies or body parts for research or education never came up during our discussions." Since then, the body trade has become big business. Only one state, New York, keeps detailed records on the industry. According to the most recent data available, companies that did business in New York shipped at least 100,000 body parts across the country from 2011 to 2014. Reuters obtained the data, which have never been made public, from the state's health department. "I feel foolish," said Jim. "I'm not a trusting person, but, you have no idea this is going on." Military officials said they took BRC's word that permission had been given. Records show at least 20 more bodies were blown up without consent.


Daily Mirror
3 hours ago
- Daily Mirror
'I donated mum's body to Alzheimer's research what happened next was horrifying'
Her son said 'she was strapped in a chair, and a detonation took place underneath her' One Arizona man thought he was donating his mother's body to science after her harrowing descent in Alzheimer's - only to discover he had been sent her cremated arm before the rest of her body was strapped to a chair and blown up. Jim Stauffer cared for his mother Doris throughout her illness before she died at 74 in 2013. He decided to donate her brain to science hoping to contribute to a cure for Alzheimer's disease. The family contacted Biological Resource Center, a local company that brokered the donation of human bodies for research. Within the hour, BRC dispatched a driver to collect Doris. Jim signed a form authorising medical research on his mother's body. Ten days later, Jim received his mother's cremated remains - but it turns out her ashes were made up of a singular arm sawn off from her body. The rest of her corpse had met a violent fate. Doris' brain never was used for Alzheimer's research. Instead, her body became part of an Army experiment to measure damage caused by roadside bombs, the Irish Star reports. Internal BRC and military records show that at least 20 other bodies were also used in the blast experiments without permission of the donors or their relatives, a violation of U.S. Army policy. Jim had also ticked a box specifically banning any kind of experiments on Doris. BRC sold donated bodies like Stauffer's for $5,893 each. Jim said: "She was strapped in a chair, and a detonation took place underneath her to get an idea of what the human body goes through when a vehicle is hit by an IED. There was wording on this paperwork about performing tests that may involve explosions, and we said, 'No'." Army officials involved in the project said they never received the consent forms that donors or their families had signed. Rather, the officials said they relied on assurances from BRC that families had agreed to let the bodies be used in such experiments. BRC, which sold more than 20,000 parts from some 5,000 human bodies over a decade, is no longer in business. Its former owner, Stephen Gore, pleaded guilty to fraud in 2022. In a statement to Reuters, Gore said that he always tried to honor the wishes of donors and sent consent forms when researchers requested them. Jim said of Gore "He didn't care about the families, he didn't care about the people." Jim learned of the fate of his mother's body from a Reuters reporter and "curled his lip in anger and clutched his wife Lisa's arm. "We did right," Lisa reassured him. "They just did not honor our wishes." No federal law regulates body brokers like BRC, and no U.S. government agency monitors what happens to cadavers pledged for use in medical education and research. "It is not illegal to sell a whole body or the parts of a body for research or education," said University of Iowa law professor Sheldon F. Kurtz, who helped modify the Uniform Anatomical Gift Act, which has been adopted by 46 states. Although the act was updated in 2006, Kurtz said, "the issue of whole bodies or body parts for research or education never came up during our discussions." Since then, the body trade has become big business. Only one state, New York, keeps detailed records on the industry. According to the most recent data available, companies that did business in New York shipped at least 100,000 body parts across the country from 2011 to 2014. Reuters obtained the data, which have never been made public, from the state's health department. "I feel foolish," said Jim. "I'm not a trusting person, but, you have no idea this is going on." Military officials said they took BRC's word that permission had been given. Records show at least 20 more bodies were blown up without consent.


North Wales Live
10 hours ago
- North Wales Live
8ft ambush shark 'more common' than thought on Welsh coast
An enigmatic species of shark known to be favour Welsh waters could be more abundant than previous suspected, scientists believe. The Angel shark, a large flat species resembling a stingray, is unique because it has evolved very differently to other types of shark. Previously only reliably spotted around the Canary Islands, catch evidence from Welsh fishermen has shown that Cardigan Bay is also a stronghold for this elusive and vulnerable species. The Welsh population had thought to be shrinking dramatically as a result of habitat damage and bycatch fishing, with one study indicating a 70% decline since 1970. A major conservation project was launched in the hope of saving a species that lingers on the sea floor, half-buried in sand and mud, waiting for prey to swim near them. They can grow up to 2.4m (8ft) long. However a new study, 'People & Nature', from the Zoological Society of London (ZSL) and Natural Resources Wales (NRW) suggests previous Angel shark counts were wide of the mark. Its authors believes changes to commercial fishing practices have seen fewer angel sharks caught. As the speckled, caramel-coloured sharks are masters of camouflage, finding them on the sea floor is virtually impossible. Instead, evidence from boat captains is the only reliable way the population can be assessed. It's now thought fishermen are catching fewer not because numbers are dwindling but because they are targeting different waters and using species-specific nets. To reach its conclusions, the ZSL-led study harnessed the expertise of Welsh fishing organisations. Co-author was Charlie Bartlett, a charter fisherman from Gwynedd, who said: 'I've spent over 50 years working along the Welsh coast, and over the years I've come to know these waters inside out. 'With their large, flat fins, Angel sharks are unlike any other shark we see here - and over the years I've been fortunate to encounter the species a number of times.' In the 40 years to 2020, some 1,642 Angel sharks were reported in Welsh coastal waters. A particular safe haven is in an area south of the Llŷn Peninsula. While they pose very little risk to humans, they have been known to bite when provoked. Literature analysis going back two centuries revealed they have a long maritime heritage in Wales. No fewer than 16 different names were uncovered, including Monkfish, Banjofish, Bafoon, Shovelnose and Devilfish. Its traditional Welsh name is Maelgi (Monkfish). The species has been adopted as the flagship species for marine conservation in Wales. Working with the Welsh Fishermen's Association (Cymdeithas Pysgotwyr) and Angling Cymru Sea Anglers, scientists interviewed 27 fishers about their operations between 1968 and 2019. It became clear modern practices involve fewer interactions with Angel sharks, leading to fewer sightings. Lead author Francesca Mason, a ZSL researcher at the Institute of Zoology's Ocean Predator Lab, said: 'There may be more Angel sharks swimming off the Welsh coast than we previously thought – we're just having a harder time spotting them. 'While this is a good sign if less Angel sharks are being caught accidentally, it also means we now need new ways to monitor them to build a more accurate picture of how these sharks are doing.' Instead of relying on chance sightings, scientists are now pinning their hopes on a novel technique involving environmental DNA (eDNA). This can build up in the shark's surroundings through the shedding of dead skin cells or blood loss from a wound. Already eDNA is being measured for Angel Shark Project: Wales, part of the wider work of Project SIARC (Sharks Inspiring Action and Research with Communities). Jake Davies, technical specialist for Project SIARC, said: 'With their excellent camouflage, one of the hardest challenges we face studying Angel sharks is simply finding them. eDNA allows us to study species without having to spot them. 'By studying eDNA in Cardigan and Carmarthen Bays, we've confirmed the presence of a range of native sharks, skates and rays - including Angel sharks - in these more turbulent waters where other monitoring methods aren't as effective. 'Fishers today may be less likely to come across Angel sharks than they were 50 years ago, but through combining this technique with local knowledge, we can continue building a stronger picture of their status and distribution along the Welsh coast.' The Angel shark work was supported by the On the Edge conservation charity, the National Lottery Heritage Fund, Welsh Government and the Welsh Government's Nature Networks Fund.